We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
The Path Towards Affordable Advanced Therapies
Erik Vaessen, Head of Sales and Marketing – Bioproduction, and Cell & Gene Therapy at FUJIFILM Irvine Scientific, recently spoke with Phacilitate—a market Read more...The Viral Appeal of Insect Cell Culture
Benefits, bottlenecks, and bioproduction
Reliable. Able to support Baculovirus Expression Vector Systems (BEVS) and viral vector production. Capable of Read more...BioInformant Goes Behind the Scenes at FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific CEO Yutaka Yamaguchi interviewed by Bioinformant
Yutaka Yamaguchi, CEO of FUJIFILM Irvine Scientific, was recently invited to sit down Read more...Leading Industry Experts Address Cell and Gene Therapy Raw Materials Supply Chain Needs
Recently Marlin Frechette, FUJIFILM Irvine Scientific's Sr. Director of Quality Systems/Regulatory Affairs/Compliance Officer & ISO Management Representative, Read more...Cell Culture Experts Share Insights and Look into the Future of Media Development
Robert Newman, PhD, Chief Scientific Officer, FUJIFILM Irvine Scientific recently participated in a panel discussion among cell culture media experts about current Read more...First Annual Walk of Hope 5K Raises Funds to Help Patients with Infertility
Hope is what keeps dreams alive and what sustains patients battling infertility through their arduous IVF journey to see their dream of a family realized. On August Read more...The Right Cell Culture Media Can Help Your NK Cell Therapy Progress to the Clinic
Cell therapy scientists searching for a potent tool to fight cancer have zeroed in on the potential of natural killer (NK) cells because they have the innate Read more...Behind the Scenes: What Factors Play a Role in High Quality IVF Media
Media developed to support ART applications play a crucial role in facilitating new life. When it comes to something so precious, it’s imperative the innovative Read more...Cohesive Control of Antibody Galactosylation for Improved Antibody Product Quality and Function
Protein-based therapeutics are dominating the pharmaceutical market due to their high-efficacy in treating complex diseases.1 The demand for antibody (Ab) drugs Read more...Go from Good Enough to Optimal Cell Culture Media
Not all cell lines are created equal—and neither is their associated media.
To achieve the desired target performance, the design and development of an optimal Read more...
Recent Posts
-
ALL IN on Innovation – Bringing New Life to CSCM-NX with the Day 0 Approach -
ALL IN on Innovation: The Next Generation of Embryo Culture Supplementation -
Interview: Bob Newman is ALL IN on Innovation -
Meet the Team: Interview with Jim O’Brien, Director of Commercial Operations, Medical Business Unit -
Meet the Team: Interview with Jennifer Brooks, Environmental Health and Safety (EHS) Manager
